Corrado, Alessia
Donato, Paolo
Maccari, Silvia
Cecchi, Raffaella
Spadafina, Tiziana
Arcidiacono, Letizia
Tavarini, Simona
Sammicheli, Chiara
Laera, Donatello
Manetti, Andrea Guido Oreste
Ruggiero, Paolo
Galletti, Bruno
Nuti, Sandra
De Gregorio, Ennio
Bertholet, Sylvie
Seubert, Anja
Bagnoli, Fabio
Bensi, Giuliano
Chiarot, Emiliano
Article History
Received: 8 June 2016
Accepted: 2 November 2016
First Online: 30 November 2016
Competing interests
: This work was sponsored by Novartis Vaccines and Diagnostics Srl, now acquired by the GSK group of companies. All authors have declared the following interests: all authors were permanent employees of Novartis Vaccines at the time of the study. Following the acquisition of Novartis Vaccines by the GSK group of companies in March, 2015, all but A.C. and T.S. are now permanent employees of the GSK group of companies. E.D.G., F.B., A.S. and S.B. report ownership of GSK shares and/or restricted GSK shares. A.C., F.B., G.B. and E.C. are listed as inventors on patents owned by the GSK group of companies.